Magnolia Neurosciences Corporation

PharmaceuticalsSeries ANew York, USmagnolianeurosciences.com

Latest round

Series A

Last raised

Aug 2018

Total raised

$8M

Investors

12

About Magnolia Neurosciences Corporation

Magnolia Neurosciences Corporation is focused on delivering advanced software solutions designed to streamline business operations. The company is headquartered in New York, US.633 mn post-money.The company offers a range of innovative products and services designed to address specific needs within its target market. Its core offerings include advanced software solutions that streamline operational efficiencies for businesses in various sectors, including finance, healthcare, and logistics. These products are engineered to enhance productivity, reduce costs, and improve overall user experience, catering primarily to small and medium-sized enterprises (SMEs) and larger corporations. The solutions have been deployed in multiple geographical markets, including North America, Europe, and parts of Asia, where they have been met with positive reception from both end-users and businesses looking to optimize their processes.The company generates revenue through a structured model that primarily includes subscription-based services and direct sales of its software solutions. Clients typically engage in annual or monthly subscription plans, which provide access to the full suite of features and continuous updates. This model fosters a stable recurring revenue stream, allowing the company to maintain strong relationships with its customer base. Additionally, the company engages in B2B transactions, collaborating with larger enterprises to provide tailored solutions that meet specific operational requirements. The company is targeting further expansion into geographical markets, specifically aiming to penetrate additional regions in Europe and Asia by the end of 2023.

Who invested in Magnolia Neurosciences Corporation

12 investors across 1 round

See all investors in Magnolia Neurosciences Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Aug 3, 2018

    Amount

    $8M

    Investors

    Locked

Questions about Magnolia Neurosciences Corporation

Who invested in Magnolia Neurosciences Corporation?

Magnolia Neurosciences Corporation has 12 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Magnolia Neurosciences Corporation raised?

Magnolia Neurosciences Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Magnolia Neurosciences Corporation last raise money?

Magnolia Neurosciences Corporation's most recent round on record is a Series A, in Aug 2018.

What does Magnolia Neurosciences Corporation do?

Magnolia Neurosciences Corporation is focused on delivering advanced software solutions designed to streamline business operations.

Where is Magnolia Neurosciences Corporation headquartered?

Magnolia Neurosciences Corporation is headquartered in New York, US.

Which VCs invest in companies like Magnolia Neurosciences Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Magnolia Neurosciences Corporation's stage. Their profiles are linked below.

Raising like Magnolia Neurosciences Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.